A nutrition-based nomogram has been developed to predict the risk of intra-abdominal infection (IAI) after D2 radical gastrectomy for gastric cancer. An analysis of 404 patients identified key indicators, including the NRS2002 score, fasting blood glucose, and multi-visceral resection, associating them with IAI risk. The nomogram demonstrated good predictive capacity (AUROC 0.744) and excellent calibration, […]

Significant preoperative amino acid elevations were found in gastric cancer patients. Post-surgery, many amino acids decreased but were partially restored with nutritional intervention, with some levels surpassing preoperative values. However, methionine and glutamine remained lower than in healthy individuals. Correlations were identified between specific amino acid changes and faster gastrointestinal recovery as well as reduced […]

A novel robotic approach for the retrosternal route in gastric conduit reconstruction has demonstrated safety and efficiency. In a study involving 43 esophageal cancer patients, the median time for creating this route was just nine minutes, with no incidences of pleural injury or postoperative hemorrhage reported. Additionally, there was no significant variation in creation time […]

A vascular navigation system significantly enhances robotic distal gastrectomy for novice surgeons, according to a study involving 49 patients. The navigation group showed reduced dissection times (179.85 vs. 204.87 minutes) and increased lymph node retrieval (41.81 vs. 30.96). Additionally, the system contributed to lower C-reactive protein levels, indicating reduced surgical trauma (8.27 vs. 11.68 mg/dl). […]

A study involving 459 gastric cancer patients showed that indocyanine green (ICG)-guided lymphadenectomy significantly enhanced survival outcomes after neoadjuvant chemotherapy. Patients in the ICG group had a higher number of lymph nodes harvested and demonstrated improved three-year overall survival (78.6% vs 66.6%) and recurrence-free survival (74.0% vs 57.0%) compared to non-ICG counterparts. Efficacy was particularly […]

A study established two nomograms to predict risks and prognosis for T1-T2 stage gastric cancer patients with lymph node metastasis. Analyzing data from 5,350 patients, key risk factors included age, tumor size, and grade. The developed nomograms demonstrated excellent calibration and clinical applicability, significantly distinguishing overall survival between low-risk and high-risk groups. These tools aim […]

A novel prognostic oxidative stress-immune-inflammation score (posii score) has been developed to enhance survival predictions for gastric cancer patients post-radical gastrectomy. Analysis of 3,612 patients revealed that those in the low posii group exhibited significantly higher 5-year overall and disease-free survival rates, along with reduced recurrence risks (p < 0.05). Two validated online calculators based […]

A multicenter retrospective study evaluated neoadjuvant immunochemotherapy involving PD-1 agents plus platinum-based chemotherapy for 213 patients with resectable esophageal cancer. The study reported a high pathological complete response (PCR) rate of 31.9%, with a complete tumor resection (R0) rate of 99.1%. Additionally, two-year disease-free survival (DFS) and overall survival (OS) rates were notable at 78.9% […]

In a multicenter study, significant differences in long-term survival were observed between patients with Epstein-Barr virus-associated gastric cancer (EBVAGC) and those with Epstein-Barr virus-negative gastric cancer (EBVNGC) after radical gastrectomy. The 3-year overall and disease-free survival rates were notably higher in the EBVAGC group. Additionally, positivity for Epstein-Barr virus-encoded small RNA served as an independent […]